The personal experience of losing a child born with a rare disease and a brother with a chronic disease became the springboard for Dr. Harsha Rajasimha to apply his years of postdoctoral training at NIH and FDA to accelerating therapies for rare and common conditions.
He knew that technology in itself is not the limiting factor and that patient-centered design guided by stakeholder needs and regulatory requirements would guide their continuous learning digital platform.
Since the inception of Jeeva Trials, it has aimed to digitize and automate manual repetitive tasks and reduce the logistical burdens on patients and study teams by over 70%. Jeeva Trials accelerate the process of bringing new medicines or vaccines to patients who need them by over 3x faster.
Jeeva Trials offers a Modular eClinical SaaS platform for the streamlined execution of Clinical Trials. It works for decentralized, hybrid, or traditional trials using a centralized schedule of visits and module configuration.
Jeeva Trials modules include eConsent, ePRO/eCOA/EDC, TeleVisits/VideoVisits, Adverse event capture with MedDRA coding, and patient engagement portal with SMS/email/audio/video communications/reminders/notifications.
